DOCSLIB.ORG

Download Final Program Here

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download Final Program Here 8th Annual Meeting of the International Cytokine & Interferon Society 1 - 4 November Virtual Meeting Structure-Function & Systems Biology of Cytokines FINAL PROGRAM www.seattle.cytokinesociety.org content 03 Welcome Message 04 Committee Members 05 Invited Speakers 06 Award Winners 07 Milstein Abstract Award Winners 08 - 09 Program Overview 10 Program Day 1 11 - 13 Program Day 2 14 - 15 Program Day 3 16 - 18 Program Day 4 21 - 35 Lightning Talks 39 Sponsors Acknowlegement 41 - 46 Company Profiles 47 Cytokines 2021 2 welcome message Dear Colleagues and partners, We would like to wish you a warm welcome to the very first Cytokines 2020 virtual Meeting, which promise to be a lively and fully interactive meeting with a flavor of Seattle! This is a unique opportunity for you to connect with more than 1000 colleagues from around the world, enjoy more than 123 presentations with live Q&A and 230 lightning talks. The ICIS Annual Meetings have a distinguished history of presenting cutting edge research from internationally recognized scientists. In recognition of the role of cytokines in COVID-19 and the extraordinary research being done by the cytokine & interferon community, the Local Organizing Committee of the International Cytokine & Interferon Society (ICIS) has re-shaped the program to include the latest findings on SARS-CoV-2/host interactions and COVID-19. The pandemic underscores the importance of this meeting and our research to understand the systems biology of cytokines and interferons in human health and disease. Nearly all of the major breakthroughs in COVID-19 treatments and vaccine development have connections to ICIS members in academia, government and industry. Reflecting the diverse scientific interests in the field of cytokine biology, sessions impacting all aspects of cytokine and interferon basic science, clinical development, and medicine will update you on these activities to reveal promising research that will lead to or has already launched cytokine- based therapeutics and immune-modifying biologics to treat COVID-19, cancer, autoimmunity, infectious disease and vaccine applications. We believe this will be a fantastic meeting with many networking and learning opportunities no matter which time zone you are in! We wish you a successful meeting! Michael Gale Jr., Chair Ram Savan, Co-Chair University of Washington University of Washington 3 committee members Local Organizing Committee International Advisory Committee Michael Gale Jr., Ph.D., Simon Jones, Ph.D., University of Washington, Seattle, USA, meeting chair Cardiff University, Cardiff, UK Ram Savan, Ph.D., Eleanor Fish, Ph.D., University of Washington, Seattle, USA, meeting co-chair FAAS, University of Toronto, Toronto, Canada Sarah Gaffen, Ph.D., Kate Fitzgerald, Ph.D., University of Pittsburgh, Pittsburgh, USA University of Massachusetts Medical School, Worcester, USA Naeha Subramanian, Ph.D., Institute for Systems Biology, Seattle, USA Georg Schett, M.D., Friedrich-Alexander-University, Erlangen, Germany Steve Ziegler, Ph.D., Benaroya Research Institute, Seattle, USA Akinori Takaoka, M.D., Ph.D., Hokkaido University, Sapporo, Japan Yueh-Ming Loo, Ph.D., AstraZeneca, Inc., Gaithersburg, USA You-Me Kim, Ph.D., Pohang University of Science and Technology, Pohang, Renee Ireton, Ph.D., South Korea University of Washington, Seattle, USA ICIS Officers & Council Members ICIS Committee Chairs Katherine A. Fitzgerald Awards Committee: President (2019-2021) Fabienne MacKay, Chair & Luke O’Neill, Co-Chair Christopher Hunter Development Committee: President-Elect (2019-2021) Simon Jones Dusan Bogunovic Finance Committee: Treasurer (2019-2021) Dusan Bogunovic John W. Schoggins Membership/Communications: Secretary (2018-2020) Stacy M. Horner & Howard Young (Co-Chairs) Nancy Reich Marshall Meetings Committee: Past President (2019-2021) Brendan Jenkins David Artis (2018 – 2020) Nomenclature Committee: Ludmila Prokunina-Olsson Sarah Gaffen (2019 – 2021) Nominating Committee: Anne O’Garra (2019 – 2021) Thomas Decker Hiroki Yoshida (2018-2020) Publications Committee: Scott Durum, Chair & Cristina Bergamaschi, Co-Chair Michael Gale Jr. Cytokines 2020 Chair Standards Committee: Gareth Jones Joan Oefner Managing Director (ex-officio) 4 invited speakers Kristina Adams-Waldorf, University of Washington, USA Jennifer Lund, Fred Hutchinson Cancer Research Center, USA Judith Allen, University of Manchester, UK Jack Major, Francis Crick Institute, UK Maninjay Atianand, University of Pittsburgh, USA Matteo Massara, University of Lausanne, CH Glen Barber, University of Miami, USA Mandy McGeachy, University of Pittsburgh, USA Ralph Baric, UNC Gillings School of Global Public Health, USA Andrew McKenzie, MRC, University of Cambridge, UK Betsy Barnes, Feinstein Institutes for Medical Research, USA Daniel McVicar, National Cancer Institute, USA Dan Barouch, Harvard Medical School, USA Vineet D. Menachery, University of Texas, USA Alina Baum, Beth Israel Deaconess Medical Center, USA Anna Molofsky, UC San Francisco, USA Sonja Best, NIH, Rocky Mountains Labs, USA Kathleen Neuzil, University of Maryland, USA Estelle Bettelli, Benaroya Research Institute, USA Timothy Nice, Oregon and Health Sciences University, USA Catherine Blish, Stanford University Medical Center, USA Mariko Okada, Osaka University, JP Igor Brodsky, University of Pennsylvania, USA Selinda Orr, Queen’s University Belfast, UK Helen Y Chu, University of Washington, USA Chandrashekhar Pasare, Cincinnati Children’s, USA Jörn Coers, Duke University, USA Louis Picker, Oregon Health & Science University, USA Antonio del Sol, University of Luxembourg, LU Fiona Powrie, University of Oxford, UK Michael Diamond, Washington University, USA Anne Puel, The Rockefeller University, USA Marlène Dreux, INSERM, FR Lalita Ramakrishnan, University of Cambridge, UK Eleanor Fish, University of Toronto, CA Gwendalyn Randolph, Washington University, USA Kate Fitzgerald, University of Massachusetts Medical School, USA Barbara Rehermann, NIH, USA Sarah L. Gaffen, University of Pittsburgh, USA Boris Reizis, NYU Langone, USA Chris Garcia, Stanford University, USA Aaron Ring, Yale University, USA Michael Y. Gerner, University of Washington, USA Ellen Rothenberg, Caltech, USA Sara Hamilton, University of Minnesota, USA John Schoggins, UT Southwestern, USA Jorge Henao-Mejia, University of Pennsylvania, USA Rafick-Pierre Sékaly, Case Western Reserve University, USA Kristin Hogquist, University of Minnesota, USA Gregory F. Sonnenberg, PhD, Cornell University, USA Stacy Horner, Duke University, USA George Stark, Cleveland Clinic, USA Curt Horvath, Northwestern University, USA Daniel Stetson, University of Washington, USA Christopher Hunter, University of Pennsylvania, USA Naeha Subramanian, Institute for Systems Biology, USA Jennifer Hyde, University of Washington, USA Mehul Suthar, Emory Vaccine Center, USA Ruaidhri Jackson, Harvard Medical School, USA Elia Tait-Wonjo, University of Washington, USA Simon Jones, Cardiff University, UK Reiko Tanaka, Imperial College London, UK Jonathan Kagan, Boston Children’s Hospital, USA Benjamin TenOever, Icahn School of Medicine, USA Eiryo Kawakami, Chiba University, JP Jenny Ting, University of North Carolina, USA Nichole Klatt, University of Minnesota, USA Shannon Turley, Genentech, USA Robyn Klein, Washington University, USA Monika Wolkers, University of Amsterdam, NL Venkatesh Gary Krishnan, Eli Lilly & Co., USA Joshua Woodward, University of Washington, USA Vijay K. Kuchroo, Harvard Medical School, USA Autumn York, Yale University, USA Warren J. Leonard, NIH, USA Ivan Zanoni, Boston Children’s Hospital, USA David Levy, NYU Langone, USA Zhenyu Zhong, UT Southwestern, USA P'ng Loke, NIAID, NIH, USA Steven Ziegler, Benaroya Research Institute, USA Carrie L. Lucas, Yale University, USA 5 2020 ICIS Award Winners The Seymour & Vivian Milstein Award for ICIS Honorary ICIS-Luminex Excellence in Interferon ICIS-BioLegend William E. Paul Award for Lifetime Membership John R. Kettman & Cytokine Research Excellence in Cytokine Research Award Early-Career Award Warren J. Leonard, MD Sarah l. Gaffen, Ph.D. Vijay K. Kuchroo, DVM, Ph.D. Anne O’Garra, FRS, FMedSci Gregory F. Sonnenberg, Ph.D. NIH Distinguished Gerald P. Rodnan Professor of Samuel L. Wasserstrom Senior Group Leader, Laboratory Associate Professor of Microbiology Investigator, Chief, Rheumatology, Director of Professor Of Neurology At of Immunoregulation & & Immunology in Medicine, Laboratory of Molecular Basic Rheumatology Research Harvard Medical School & Infection, The Francis Crick Department of Medicine, Immunology, and Director, University of Pittsburgh School Director, Evergrande Center For Institute, London, England Gastroenterology Division, Immunology Center, of Medicine Department of Immunologic Diseases Harvard Department of Microbiology & National Heart, Lung, and Medicine, Division of Medical School And Brigham Immunology, Jill Robert’s Institute Blood Institute, NIH, Rheumatology and Clinical And Women’s Hospital, for Research in IBD, Weill Cornell Bethesda, U Immunology, Pittsburgh, USA Boston, USA Medicine, Cornell University, New York, NY USA ICIS Distinguished Milstein Young Investigator The Christina Service Award Awards Fleischmann Award to Young Women Investigators Joan Saluzzi-Oefner Aaron M Ring, MD, Ph.D. Elia Tait Wojno, Ph.D. Zhenyu Zhong, Ph.D. Carrie L Lucas, Ph.D. ICIS Managing Director Assistant Professor of Assistant Professor Assistant ProfessorDepartment of Assistant Professor of Regensburg, Germany – Immunobiology Department
Load more

Recommended publications
  • Cytokines MONTRÉAL 2008
    Cytokines MONTRÉAL 2008 Translating Science into Health: Cytokines in Cancer, Infl ammation and Infectious Diseases 7th Joint Conference of the International Cytokine Society and the International Society for Interferon and Cytokine Research Photo: Tourisme Montréal Photo: Tourisme October 12-16, 2008 Fairmont Queen Elizabeth Hotel Montreal Quebec CANADA Cytokines Montreal 2008 1 PROGRAM From cell separation to molecular analysis The Gold Standard in Cell Isolation • Separation of functional, cytokine-secreting cells • Virtually any cell type from any species • Superior viability, purity and recovery Cytokines and Growth Factors • New, broad portfolio: human - mouse - rat • Excellent purity and activity • Optimized for cell culture applications MACSmolecular Tools for Molecular Analysis • Tools for signal transduction • State of the art microRNA analysis • Comprehensive gene expression profiling Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. Miltenyi Biotec Inc. Phone 800 FOR MACS www.miltenyibiotec.com 12740 Earhart Avenue +1 530 888 8871 [email protected] Auburn CA 95602, USA Fax +1 530 888 8925 2 Cytokines Montreal 2008 ContentsWelcome to Montreal ..................................................................................... 4-5 Sponsors and Exhibitors ................................................................................... 6 Conference Venue ...........................................................................................
    [Show full text]
  • Beyond Vaccines: Promising Therapeutics for COVID-19 and Emerging Viruses
    Research Canada speaks to Dr. Eleanor Fish, a scientific advisor to Canada’s COVID- 19 Therapeutics Task Force Beyond Vaccines: Promising Therapeutics for COVID-19 and Emerging Viruses The federal government’s COVID-19 Therapeutics Task Force provides advice on the best and most promising treatments for COVID-19 procurement, whether these are still in development and merit support, including via applications to the federal Strategic Innovation Fund, or are existing medications. The Task Force also makes recommendations on therapies developed for a different use that may have an application to COVID-19. Dr. Eleanor Fish is among 11 science advisors to the Therapeutics Task Force. A Professor of Immunology at the University of Toronto and a Senior Scientist at University Health Network, she investigates the behaviour of cytokines, which play a role in cell-to-cell communication during the body’s immune response. In a recent Research Canada interview with Ms. Deborah Gordon-El- Bihbety, President and CEO, Dr. Fish talked about the critical place of therapeutics in the battle against COVID-19, and their important role in preparing for the diseases and epidemics to come. "Vaccines are a very important tool in our toolbox against COVID-19, but they are not a complete solution." - Dr. Eleanor Fish 1 RESEARCH CANADA: Canada’s vaccination campaign is under way, and we’ve been told that all Canadians who want a vaccine will have it by next fall. What role do therapeutics play, separate from vaccines, in the fight against COVID-19? DR. ELEANOR FISH: Vaccines are a very important tool in our toolbox against COVID-19, but they are not a complete solution.
    [Show full text]
  • TUC Congress 2016: GPC Report, Composite Motions, Emergency
    CONGRESS 2016 GPC REPORT, COMPOSITE MOTIONS, EMERGENCY MOTION AND GENERAL COUNCIL STATEMENT The 148th Annual Trades Union Congress 11–14 September 2016, Brighton CONTENTS SECTION ONE GPC REPORT TO CONGRESS 04 SECTION TWO CONGRESS TELLERS AND SCRUTINEERS 10 SECTION THREE COMPOSITE MOTIONS 01–15 11 SECTION FOUR EMERGENCY MOTION 31 SECTION FIVE GENERAL COUNCIL STATEMENT 32 CONTENTS 03 SECTION ONE GPC REPORT TO CONGRESS Part 1 Agenda All motions and amendments stand as in the Agenda unless indicated otherwise below. Where composite motions have been agreed and approved by the GPC by 7 September, they are shown in the list below and the text of the composite motion is given in Section Three of this report. Composite motions agreed and approved by the GPC after 7 September will be reported to Congress by the GPC and copies circulated to delegates as quickly as possible. Where movers of motions have agreed to accept published amendments by 7 September, this is also stated in the list below. The GPC will report to Congress all instances where published amendments are accepted by the movers of motions after 7 September. The following is the position at 7 September in respect of motions, amendments and composite motions. Motion numbers are those printed in the Agenda. 1. JOBS, GROWTH AND A NEW ECONOMY 01 Unite Composite 01 European Union 02 UNISON 03 FBU amend CWU 04 Community 05 FDA Composite 02 amend GMB Making a success of Brexit amend PCS 06 GMB Composite 03 amend Prospect Supporting a modern amend ASLEF industrial strategy 07 Unite Composite 04 Steel 08 Community amend ASLEF 09 Prospect Composite 05 amend USDAW Working harder not smarter amend ATL SECTION ONE GPC REPORT TO CONGRESS 04 10 Nautilus International Stands 11 TSSA Stands amend BALPA not accepted 12 BDA Stands amend NASUWT accepted 13 Aegis Stands amend FDA accepted 14 USDAW Composite 06 amend UNISON Living wage amend RMT 15 BFAWU amend PCS 16 TUC Young Workers Conference Stands 2.
    [Show full text]
  • ISICR Vol. 15.1
    ISICR Officers President Eleanor Fish President-elect INTERNATIONAL SOCIETY FOR Leonidas Platanias INTERFERON AND CYTOKINE RESEARCH Secretary April 2008 Tom Hamilton Volume 15, No. 1 Treasurer Bob Friedman Executive Director A Message from the new ISICR Cliff Brownstein President, Eleanor Fish It is with gratitude and humility that I assume the Future ISICR Meetings responsibilities of incoming President of the ISICR. I am honored to have been elected by my peers and am fortunate to have in place a Board of 2008 Meeting Directors and Committee members that are as Joint ISICR/ICS committed to strengthening our Society as I am. In Montreal, Canada recent months, to ensure that our Society reflects Oct. 12-16 the scientific activities of junior investigators, as positions have www.cytokines2008.org become vacant on the various ISICR Committees, in consultation 2009 Meeting with the Committee Chairs I have made best efforts to invite the par- Joint ISICR/ICS/SLB ticipation of younger investigators who share our vision of a strong, Lisbon, Portugal international, collegial Society. I invite members to participate in your Society - just contact me to let me know of your interest. 2010 Meeting Joint ISICR/ICS Within recent years we have seen a revival of interest in the Chicago, Illinois pleiotropic activities of interferons, touching on many different bio- logical disciplines. Moreover, the role of cytokines and how they ISICR WWW Site inform us of biological processes in normal and diseased states is an www.ISICR.org ever expanding field. I would like to focus my tenure as President on a number of key areas: ISICR Business Office O Communication.
    [Show full text]
  • Dec 08 News Vol 15 No 3 Final.Qxp
    ISICR Officers President Eleanor Fish President-elect Leonidas Platanias Secretary Tom Hamilton December 2008 - Volume 15, No. 3 Treasurer Bob Friedman Executive Director One on one: An Interview with Cliff Brownstein Giorgio Trinchieri, Recipient of the 2008 Milstein Award Future ISICR Meetings Thomas Tan 2009 Meeting Giorgio Trinchieri received his medical degree Joint ISICR/ICS/SLB from the University of Torino, Italy, in 1973. He Lisbon, Portugal was a member of the Basel Institute for Immunology (Basel, Switzerland) and an investi- 2010 Meeting gator at the Swiss Institute for Experimental Joint ISICR/ICS Cancer Research (Epalanges sur Lausanne, Chicago, Illinois Switzerland). From 1979 to 1999 he was at Wistar Institute in Philadelphia and became Hilary Koprowski Professor and Chairman of the Immunology Program; he ISICR WWW Site was also Wistar Professor of Medicine at the University of www.ISICR.org Pennsylvania. He then served as director of the Schering Plough Laboratory for Immunological Research in Dardilly, France, and an ISICR Business Office NIH Fogarty Scholar at the Laboratory for Parasitic Diseases, [email protected] NIAID, before becoming director of the Cancer and Inflammation TEL: 301-634-7250 Program (CIP) and Chief of the Laboratory of Experimental FAX: 301-634-7420 Immunology at NCI in August 2006. As CIP director, he oversees the operations of two major NCI intramural laboratories, the Laboratory ISICR Newsletter Editors of Experimental Immunology and the Laboratory of Molecular Howard Young Immunoregulation. These two laboratories constitute the major [email protected] immunologic component of the inflammation and cancer initiative, Fax: 301-846-1673 which spans the NCI's campuses in Frederick and Bethesda and seeks Hannah Nguyen to partner NCI's expertise in inflammation and immunology with its cutting-edge cancer etiology and carcinogenesis program.
    [Show full text]
  • DCC Plc Annual Report and Accounts 2019
    DCC plc Annual Report and Accounts 2019 WorldReginfo - 47739327-57d6-4662-9440-8b5adb4dd3e6 DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth, which operates across four divisions: LPG, Retail & Oil, Technology and Healthcare. DCC is an ambitious and entrepreneurial business operating in 17 countries, supplying products and services used by millions of people every day. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. LPG Retail & Oil Technology Healthcare Page 42 Page 48 Page 54 Page 60 Strategic Report Governance Financial Statements ii DCC at a Glance 73 Chairman’s Introduction 124 Statement of Directors’ 1 Highlights of the Year 74 Board of Directors Responsibilities 2 Strategy 76 Group Management Team 125 Independent Auditor’s Report 4 Business Model 77 Corporate Governance Statement 129 Financial Statements 6 Chairman’s Statement 84 Nomination and Governance 8 Chief Executive’s Review Committee Report Supplementary Information 88 Audit Committee Report 10 Key Performance Indicators 210 Principal Subsidiaries, Joint Ventures 14 Risk Report 93 Remuneration Report and Associates 21 Financial Review 119 Report of the Directors 214 Shareholder Information 30 Strategy in Action 216 Corporate Information 42
    [Show full text]
  • Labour and the Trade Unions
    Centre forPolicyStudies THE THE AUTHORS Jonathan Djanogly has been MP for Huntingdon since 2001. He is a qualified solicitor and is currently Shadow Solicitor General and Shadow Minister for Business, Enterprise and Regulatory Reform. Alan Duncan has been MP for Rutland and Melton since 1992. He is currently Shadow Secretary of State for Business, Enterprise and Regulatory Reform. The aim of the Centre for Policy Studies is to develop and promote policies that provide freedom and encouragement for individuals to pursue the aspirations they have for themselves and their families, within the security and obligations of a stable and law- abiding nation. The views expressed in our publications are, however, the sole responsibility of the authors. Contributions are chosen for their value in informing public debate and should not be taken as representing a corporate view of the CPS or of its Directors. The CPS values its independence and does not carry on activities with the intention of affecting public support for any registered political party or for candidates at election, or to influence voters in a referendum. Centre for Policy Studies, November 2007 ISBN No: 978-1-905389-64-3 Centre for Policy Studies 57 Tufton Street, London SW1P 3QL Tel: 020 7222 4488 Fax: 020 7222 4388 e-mail: [email protected] website: www.cps.org.uk Printed by The Centre for Policy Studies, 57 Tufton Street, London SW1P 3QL CONTENTS SUMMARY AND RECOMMENDATIONS 1. TRADE UNION DONATIONS TO THE LABOUR PARTY 1 2. STRENGTHENING THE TRADE UNIONS 6 3. CONCLUSION 14 APPENDIX 1 TRADE UNION DATA APPENDIX 2 METHODOLOGY FOR CALCULATING TRADE UNION DONATIONS APPENDIX 3 LIST OF EMPLOYMENT LEGISLATION SINCE 1997 SUMMARY The Labour Government has, since 1997, made much of its “business- friendly” credentials.
    [Show full text]
  • House of Commons Public Administration Select Committee Future of the Civil Service
    House of Commons Public Administration Select Committee Future of the Civil Service Written Evidence List of written evidence 1. The Universities of Birmingham and Sheffield ‘Shrinking the State’ ESRC Research Project (CSR 1) 2. Dr Andrew Blick, Centre for Political and Constitutional Studies, King’s College London (CSR 2) 3. Prospect (CSR 3) 4. Public and Commercial Services Union (PCS) (CSR 4) 5. Institute for Government (CSR 5) 6. First Division Association (FDA) (CSR 6) 7. Project Management Institute (CSR 7) 8. Parliamentary and Health Service Ombudsman (PHSO) (CSR 8) 9. Cabinet Office (CSR 9) 10. Martin Surr (CSR 10) 11. Mr Patrick Diamond, Professor David Richards and Professor Martin Smith (CSR 11) 12. Dr Suzy Walton (CSR 12) 13. Sir John Elvidge (CSR 13) 14. Mark Balchin (CSR 14) 15. Professor Howard Elcock (CSR 15) 16. Dr Chris Gibson-Smith (CSR 16) 17. Dr Ruth Levitt and William Solesbury, Visiting Senior Research Fellows, Dept of Political Economy, King's College London (CSR 17) 18. D H Owen (CSR 18) 19. Philip Virgo (CSR 19) 20. Active Operations Management International LLP (CSR 20) 21. Association for Project Management (CSR 21) 22. Additional evidence from FDA (CSR 22) 23. Dr John Parkinson, The University of Warwick (CSR 23) 24. Civil Service Commission (CSR 24) 25. Professor Matthew Flinders (University of Sheffield), Professor Chris Skelcher (University of Birmingham), Dr. Katharine Dommett (University of Sheffield) & Dr Katherine Tonkiss (University of Birmingham) (CSR 25) 26. Professor the Lord Norton of Louth (CSR 26) 27. Rt Hon Jack Straw MP (CSR 27) 28. Civil Service Commission (CSR 28) 29.
    [Show full text]
  • Annual Report
    Association of Higher Civil and Public Servants Comhlachas na Sheirbhíseach Uachtarach Stáit agus Poiblí Annual Report 1921 CONFIDENTIAL TO MEMBERS Association of Higher Civil and Public Servants Comhlachas na Sheirbhíseach Uachtarach Stáit agus Poiblí ANNUAL REPORT 2019/2021 1 AHCPS Annual Report 2019/2021 CONTENTS Officers, Executive Committee and Consultative PART THREE: STATE ENTERPRISES Council 2019/2021, Sub-Committees. 3.1 An Post 31 3.2 Irish Aviation Authority 31 INTRODUCTION 9 3.3 Premier Lotteries Ireland (PLI) 33 3.4 Solas / Education Training Boards (ETB) 33 PART ONE: ORGANISATION 3.5 Food Safety Authority of Ireland (FSAI) 33 1.1 Annual Delegate Conference 11 3.6 Other Agencies 33 1.2 Executive Committee 11 1.3 Standing Orders Committee 11 PART FOUR: AFFILIATIONS AND RELATIONS WITH 1.4 ADC Resolutions 2019 including OTHER ORGANISATIONS Motions Remitted 11 4.1 Irish Congress of Trade Unions 35 1.5 Trustees and Auditor 17 4.2 Public Services Committee 35 1.6 Honorary President & Vice Presidents 17 4.3 ICTU Women’s Committee 35 1.7 Consultative Council 17 4.4 ICTU Global Solidarity Committee 35 1.8 Events for Members 17 4.5 ICTU Youth Committee 35 1.9 Membership 17 4.6 ICTU Housing Campaign 35 1.10 Social Media and Communications Technology 18 4.7 NERI 36 1.11 Bereavement Grant 18 4.8 ICTU Peoples College 36 1.12 Membership Services 18 4.9 ICTU Retired Workers’ Committee 36 1.13 Rules & Constitution 20 4.10 Veterinary Officers’ Association 36 1.14 Staff 20 4.11 Civil Service Unions 37 4.12 Retired Civil & Public Servants’ Association
    [Show full text]
  • Healthy Conversations Over Time! Read on for Further Details
    HEALTHY Conversations An Interactive Guide to Making Positive Change HEALTHY Conversations A guide for Community Health Workers about mental health and substance use to support clients making positive change Copyright 2014 Anansi Health Images from iStockphoto.com, with the exception of the gratitude jar on page 192, copyright Tiare Smith HOW TO USE THIS GUIDE This guide was written to help support direct care staff, including case managers, peer advocates, patient navigators, etc. to build healthy working relationships with their clients who struggle with mental health, substance use, or both. The goal is to facilitate honest, meaningful conversations that empower the client to understand their issues better and make small, positive steps to improve their health. The language we use here, Community Health Worker (CHW), is meant as an umbrella term for folks who work directly with clients in their homes, clinic, or community setting to improve health outcomes and quality of life. Please feel free to adapt the terms here to fit with your program (ie: change the word client to patient, consumer, or member, whatever your participants like to be called). We hope it will be a jumping off point for all kinds of healthy conversations over time! Read on for further details. Goals: • Build relationship and trust between Community Health Worker (CHW) and the client • Assess client’s issues, strengths, goals, dreams, perspective, and motivation about their mental health and/or substance use issues • Uncover barriers to optimal health, engagement
    [Show full text]
  • An Exploration of Enterprise Level Partnership and the Influences Informing Private Sector Organisations Choice of This Model in the Republic of Ireland
    Technological University Dublin ARROW@TU Dublin Masters Business 2006-7 An Exploration of Enterprise Level Partnership and the Influences Informing Private Sector Organisations Choice of this Model in the Republic of Ireland Kevin O'Leary Technological University Dublin Follow this and additional works at: https://arrow.tudublin.ie/busmas Part of the Business Administration, Management, and Operations Commons, and the Marketing Commons Recommended Citation O'Leary, K. (2006). An Exploration of Enterprise Level Partnership and the Influences Informing Private Sector Organisations Choice of this Model in the Republic of Ireland. Masters dissertation. Technological University Dublin. doi:10.21427/D74K7Z This Theses, Masters is brought to you for free and open access by the Business at ARROW@TU Dublin. It has been accepted for inclusion in Masters by an authorized administrator of ARROW@TU Dublin. For more information, please contact [email protected], [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License An Exploration qf Enterprise Level Partnership and the Influences Inform i7zg Private Sector Organisations ' CIzoice qf this Model in the Reptrblic ofIreland Kevin 0 'Leary Thesis submitted for fulfilment of the award of Master of Philosopliy Degree (MPhil) Dublin Institute of Technology Supervised by: Serge Basini School of Marketing July 2006 Declaration I ccrtify that this thesis which I now submit for examination for the award of Master of PElilosophy degree (MPhil), is entirely my own work and has not been taken from the work of others save and to the extent that such work has been cited and acknowledged within the text of my work, This thesis was prepared according to the regulations for postgraduate study by research of the Dublin Institute of Tecl~nologyand has not been submitted in wl~olcor UI part for an award in any other Tnstitute or University.
    [Show full text]
  • Work Stress Guide Handbook’
    No. 247/2018 24 April 2018 Our Ref: P1/18 UK National Work Stress Network – New ‘Work Stress Guide Handbook’: To: All Branches Dear Colleagues, The UK National Work Stress Network is a voluntary organisation that campaigns to secure proper recognition of the damage caused by work-stress and to prevent work-related stress. They aim to educate and raise awareness of work-stress and to improve legislation on health, safety and employment rights in the UK and Europe. The organisation is part of the ‘Hazards Campaign’ and has close links to the Trade Union movement. The UK National Work Stress Network consists of unpaid volunteers, bringing together workplace trade union and health and safety representatives, academics, safety professionals and others to campaign for the better protection of workers against stress-related mental and physical illnesses caused by poorly controlled workplace psycho-social hazards. The UK Work-Stress Network has been fighting for years alongside Trade Unions and the Hazards Campaign for the protection of Health and Safety in the workplace, action on Stress and Mental Health. The organisation, Trade Unions and the TUC, now have major concerns about the outcome of any shift of EU-based health and safety law into UK law and the very likely future diminution of Health and Safety and other associated laws. The latest edition of “Work Stress Guide” handbook has been published with the CWU being one of the publication’s sponsors, along with several other Unions; FBU, FDA, GMB, NASUWT, UNISON, Unite and both the Hazards Campaign and Scottish Hazards. The New handbook examines: The problem: The extent of work-related stress illness.
    [Show full text]